Microneedle Drug Delivery Systems Market Size was valued at USD 6.1 billion in 2023 and is expected to reach USD 11.6 billion by 2032, growing at a CAGR of 7.4% over the forecast period 2024-2032.
The Global Microneedle Drug Delivery Systems Market is experiencing significant growth, owing to rising incidences of chronic diseases and rising demand for effective delivery of drugs. It mentions that 71% of all global deaths are attributed to chronic diseases according to the World Health Organization (WHO) with cardiovascular diseases, cancer, respiratory diseases, and diabetes as the leading causes of death. Therefore, the demand for advanced drug delivery systems to enhance patient outcomes while minimizing healthcare costs is on the rise. According to the U.S. Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the United States have a chronic disease, and 4 in 10 adults have two or more chronic conditions. Such an umbrella of these chronic diseases has propelled government initiatives to improve healthcare provisioning and a high focus on research in advanced drug delivery systems. For instance, the National Institutes of Health (NIH) has increased its funding for research on microneedle technology, allocating over $50 million in grants for related projects in the past five years.
The European Medicines Agency (EMA) has also recognized an increasing contribution of microneedles to address therapeutic outcomes in chronic disease management across Europe. They demonstrate their focus on clinical trials using microneedle technology through their investment in several funding programs in 2023 for the advancement of these technologies. Also, the increasing prevalence of chronic diseases such as diabetes and rising demand for self-administered medications in Asia-Pacific is poised to drive government expenditure on advanced drug delivery systems. The government of China invested more than $20 million in microneedles in 2023 in their efforts to improvement of healthcare infrastructure.
Market Dynamics
Drivers
The increasing incidence of chronic conditions like diabetes and cardiovascular diseases is driving the demand for efficient and patient-friendly drug delivery methods.
Innovations in microneedle design and materials, such as biodegradable and dissolvable microneedles, enhance safety and expand applications.
Patients increasingly prefer self-administering medications at home, reducing hospital visits and healthcare costs, thereby boosting the adoption of microneedle systems.
Rapidly increasing occurrences of chronic diseases such as diabetes, cardiovascular diseases, and cancer are some of the major factors that are contributing to the growth of the microneedle drug delivery systems market. The rising burden of chronic diseases needs better and more patient-centric drug delivery techniques. Chronic diseases typically require treatment over the long term, which historically meant injectable drugs. However, the pain and discomfort related to the conventional injections may hinder patient adherence due to long-term disease management. Microneedles offer a minimally invasive alternative, delivering medications through the skin without the need for large, painful needles. They have been especially useful for diabetes, a condition that requires frequent administration of insulin. The World Health Organization (WHO) estimates that over 537 million adults were living with diabetes as of 2021, with a projected increase to 783 million by 2045. The fast-growing diabetic population is driving the need for a non-invasive alternative to needles such as microneedles.
Additionally, microneedles are being explored for vaccines, pain management, and hormone therapies, which enhances their appeal. For instance, they have developed microneedle patches for flu vaccines that provide a needle-free pain-free option for vaccination. As their technology matures, there is increasing interest in the clinical efficacy of these methods making them an attractive candidate for chronic disease management in countries such as the US. The growing inclination towards minimally invasive and self-delivery therapeutic options is also projected to propel the microneedle drug delivery system market growth.
Restraints
Developing effective and safe delivery systems for a wide range of therapeutics is complex, involving considerations of molecular size, stability, and formulation requirements.
The substantial investment required for R&D in microneedle technologies can be a barrier, especially for smaller companies with limited resources.
The high cost involved in research and development (R&D) is one of the major factors limiting the growth of the microneedle drug delivery systems market. Innovative microneedle technologies necessitate heavy initial investments in design, materials, and clinical testing. This is a lengthy and resource-demanding process that requires generations of prototyping, lab testing, and regulatory approvals before being embarked on by industry in earnest as a reliable drug delivery system. In addition, developing safe, efficacious microneedles that are compatible with many drug formulations adds to the financial burden. Smaller companies, in particular, may struggle to secure the necessary funding to support these extensive R&D efforts. This financial barrier can slow down the pace of innovation and hinder the market entry of new products. Furthermore, ongoing testing and refinement are required to overcome challenges related to patient comfort, dosage accuracy, and long-term stability, contributing to the overall cost.
By Type
The hollow microneedle segment held a dominant revenue share of over 26% in 2023. Reasons behind this dominance include the versatility of the segment in terms of the range of drugs and vaccines that can be administered. Hollow microneedles provide accurate control of drug volume and delivery rate and are particularly appropriate for the delivery of insulin and other biologics. The International Diabetes Federation (IDF) states that about 537 million adults around the world will live with diabetes in 2021, and this number is predicted to climb to 643 million by the year 2030. The increasing diabetic population has massively increased the requirement for efficient insulin delivery systems, which is expected to drive the growth of hollow microneedles.
In addition, devices based on hollow microneedle technology have been approved by the U.S. Food and Drug Administration (FDA) for multiple applications. As an example, a vacant microneedle system used for intradermal injection of fluids was cleared by the FDA in 2020, the FDA granted clearance to a hollow microneedle system for intradermal injection of fluids, highlighting the regulatory acceptance of this technology. Similar research focused on hollow microneedle technology has received substantial funding through the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and it is both attractive and revolutionary as a drug delivery platform. These government initiatives and the increasing prevalence of chronic diseases requiring frequent drug administration have contributed to the segment's substantial market share.
By Material
In 2023, the metal material segment led the market with a revenue share of over 29%. The notable share of this market for metal microneedles can primarily be linked to the dominant biocompatibility and mechanical properties of metal microneedles, particularly stainless steel and titanium microneedles. They are therefore composed of strong and durable metal that provides for sustained delivery of medications. NIST has developed appropriate norms for the development and quality control of metal microneedles that guarantee their safety and efficacy. This regulatory support has propelled confidence in the metal-based microneedle systems among healthcare players and patients.
Ongoing investments in research by the U.S. Department of Defense for metal microneedles for rapid vaccine delivery that is promising in military situations has also fueled this space. According to the World Health Organization (WHO), global vaccination coverage has stagnated at 86% in recent years, with no significant changes since 2010. Now, however, metal microneedles could be the answer to higher vaccination rates, as they could be made pain-free and easier to administer than conventional needles. The potential of metal microneedles has also been recognized by regulatory authorities, with the European Medicines Agency (EMA) issuing guidance for their development and use within drug delivery systems. This regulatory support, in addition to the material's established record in medical devices, has resulted in a dominant market position for the metal segment.
By Application
In 2023, the drug delivery segment accounted for the largest revenue share of 35%. There are several reasons behind such a large share of the market which includes the increasing need for effective and painless methods of drug delivery especially for chronic conditions requiring repeated doses. According to the U.S. Centers for Disease Control and Prevention (CDC), as of 2020, 6 in 10 adults in the United States had a chronic disease, and 4 in 10 adults had two or more chronic conditions. The large burden of chronic diseases has driven a need for better drug delivery systems that can improve patient adherence and clinical outcomes. Microneedle-based drug delivery has received growing interest among research agencies like the National Institutes of Health (NIH), which has funded innovative microneedle projects with applications in pain control, hormone replacement therapy, and cancer control. In 2019, the NIH provided $2.3 million for a grant that would create patches that contain microneedles for chemotherapy drug delivery. Moreover, the U.S. Food and Drug Administration (FDA) has gradually increased the attention toward microneedle technology for drug delivery and published several guidance documents to stimulate the research and development of microneedle drug delivery system (MDDS)-based products. The regulatory support has bolstered the investments of pharmaceutical companies in the microneedle drug delivery systems, thereby promoting the growth of the segment.
In 2023, North America led the microneedle drug delivery systems market, held around 42% of revenue share of the total market. Factors such as well-established healthcare infrastructure, high healthcare expenditure, and presence of major market players contributes to the dominance of this region. The United States, in particular, has been at the forefront of microneedle technology development and adoption. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending reached $4.1 trillion in 2020, representing 19.7% of the country's GDP. This large investment in health care has promoted the rapid implementation of new drug delivery technologies including microneedle systems. In addition, the U.S. Food and Drug Administration (FDA) has also recognized the importance of microneedle-based products, issuing guidance documents for the development of such products and approving a number of devices in recent years.
The fastest CAGR during the forecast period is projected in the Asia Pacific region. The rapid growth of this market is attributed to a number of reasons such as increasing prevalence of chronic diseases, rising healthcare expenditure, and the growing government initiatives to support healthcare access. According to the World Health Organization (WHO), the Western Pacific region, which includes many Asian countries, accounts for 39% of the global burden of chronic diseases. The high disease burden has resulted in the initiation of advanced healthcare technologies by governments in the region. For instance, the Japanese government has launched the "Healthcare 2035" initiative, which aims to promote the development and adoption of innovative medical technologies, including microneedle drug delivery systems. Similarly, the Indian Council of Medical Research (ICMR) has been supporting research on microneedle-based technology for vaccine delivery due to its potential to increase immunization coverage in the far-flung corners of the nation. The market in Asia Pacific is expected to gain high revenue growth due to these government initiatives along with the huge and growing population of this region.
In January 2024, BD launched a micros needle parenteral delivery system for biologics as well it features a smart device connected to a patient smartphone to track adherence in real time and provide feedback to the provider.
Nanopass Technologies launched its microneedle array patch for large-molecule drug delivery in February 2024, receiving approval from the FDA for the new treatment of autoimmune diseases.
Vaxxas received a contract from the U.S. Department of Defense worth $50 million in March 2024, with the aim of both rapid vaccine delivery in emergencies and the development of a microneedle patch.
Key Service Providers/Manufacturers
3M Healthcare (Microstructured Transdermal System, Hollow Microneedle Patch)
Becton, Dickinson and Company (MicronJet, BD Nano Pen Needle)
Zosano Pharma Corporation (Qtrypta, Adhesive Microneedle Patch)
NanoPass Technologies Ltd. (MicronJet600, NanoPass Injector)
Corium, Inc. (Corplex Transdermal System, MicroCor Patch)
Valeritas Holdings, Inc. (V-Go Wearable Insulin Delivery Device, Valeritas Microneedle System)
Raphas Co., Ltd. (SmartJet Microneedle, CosRX Pimple Patch)
Lohmann Therapie-Systeme AG (LTS) (Microneedle Applicator, LTS Patch Technology)
Micropoint Technologies (Solid Microneedle System, Hollow Microneedle Device)
TheraJect Inc. (PatchPump, Microneedle Biodegradable Systems)
Vaxxas Pty Ltd. (Nanopatch Vaccine Delivery, Micropatch Transdermal Delivery)
Altea Therapeutics Corporation (PassPort Patch, Drug-in-Patch Technology)
Debiotech SA (MicroNeedle Array System, Microfluidic Delivery System)
QuadMedicine, Inc. (Quad-MP Microneedle Patch, Transdermal Drug Delivery Patch)
Innoture Medical Technology (Skin-Micro Patch, Medical-Grade Microneedle Array)
Circassia Pharmaceuticals plc (Tixagevimab Microneedle Patch, Circassia Inhalable Systems)
Viveve Medical, Inc. (Viveve Patch, Dermal Drug Delivery System)
Zhejiang Dingjiu Machinery Co., Ltd. (Micro-Injection System, Hollow Microneedle Set)
Biolinq, Inc. (Biolinq Microneedle Patch, Continuous Glucose Monitoring System)
Mercator MedSystems, Inc. (Bullfrog Micro-Infusion System, Transdermal Microneedle Kit)
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 6.1 Billion |
| Market Size by 2032 | USD 11.6 Billion |
| CAGR | CAGR of 7.4% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Solid, Hollow, Dissolving, Coated, Others) • By Material (Silicon, Metal, Polymer, Others) • By Application (Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | 3M Healthcare, Becton, Dickinson and Company, Zosano Pharma Corporation, NanoPass Technologies Ltd., Corium, Inc., Valeritas Holdings, Inc., Raphas Co., Ltd., Lohmann Therapie-Systeme AG (LTS), Micropoint Technologies, TheraJect Inc., Vaxxas Pty Ltd., Altea Therapeutics Corporation, Debiotech SA, QuadMedicine, Inc., Innoture Medical Technology, Circassia Pharmaceuticals plc, Viveve Medical, Inc., Zhejiang Dingjiu Machinery Co., Ltd., Biolinq, Inc., Mercator MedSystems, Inc. |
| Key Drivers | • The increasing incidence of chronic conditions like diabetes and cardiovascular diseases is driving the demand for efficient and patient-friendly drug delivery methods. • Innovations in microneedle design and materials, such as biodegradable and dissolvable microneedles, enhance safety and expand applications. |
| Restraints | • Developing effective and safe delivery systems for a wide range of therapeutics is complex, involving considerations of molecular size, stability, and formulation requirements. • The substantial investment required for R&D in microneedle technologies can be a barrier, especially for smaller companies with limited resources. |
Ans. The projected market size for the Microneedle Drug Delivery Systems Market is USD 11.6 Billion by 2032.
Ans: The North American region dominated the Microneedle Drug Delivery Systems Market in 2023.
Ans. The CAGR of the Microneedle Drug Delivery Systems Market is 7.4% During the forecast period of 2024-2032.
Ans: The major key players in the market are 3M Healthcare, Becton, Dickinson and Company, Zosano Pharma Corporation, NanoPass Technologies Ltd., Corium, Inc., Valeritas Holdings, Inc., Raphas Co., Ltd., Lohmann Therapie-Systeme AG (LTS), Micropoint Technologies, TheraJect Inc., Vaxxas Pty Ltd., Altea Therapeutics Corporation, Debiotech SA, QuadMedicine, Inc., Innoture Medical Technology, Circassia Pharmaceuticals plc, Viveve Medical, Inc., Zhejiang Dingjiu Machinery Co., Ltd., Biolinq, Inc., Mercator MedSystems, Inc., and others in final report.
Ans:
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Market Adoption Rates (2023)
5.2 Incidence and Prevalence of Targeted Diseases (2023)
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending on Drug Delivery Systems (2023)
5.5 Feature Analysis, by Type of Microneedle Technology (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Microneedle Drug Delivery Systems Market Segmentation, By Type
7.1 Chapter Overview
7.2 Solid
7.2.1 Solid Market Trends Analysis (2020-2032)
7.2.2 Solid Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Hollow
7.3.1 Hollow Market Trends Analysis (2020-2032)
7.3.2 Hollow Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Dissolving
7.4.1 Dissolving Market Trends Analysis (2020-2032)
7.4.2 Dissolving Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Coated
7.5.1 Coated Market Trends Analysis (2020-2032)
7.5.2 Coated Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Others
7.6.1 Others Market Trends Analysis (2020-2032)
7.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Microneedle Drug Delivery Systems Market Segmentation, By Material
8.1 Chapter Overview
8.2 Silicon
8.2.1 Silicon Market Trends Analysis (2020-2032)
8.2.2 Silicon Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Metal
8.3.1 Metal Market Trends Analysis (2020-2032)
8.3.2 Metal Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Polymer
8.4.1 Polymer Market Trends Analysis (2020-2032)
8.4.2 Polymer Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Microneedle Drug Delivery Systems Market Segmentation, By Application
9.1 Chapter Overview
9.2 Dermatology
9.2.1 Dermatology Market Trends Analysis (2020-2032)
9.2.2 Dermatology Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Drug Delivery
9.3.1 Drug Delivery Market Trends Analysis (2020-2032)
9.3.2 Drug Delivery Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Pain Management
9.4.1 Pain Management Market Trends Analysis (2020-2032)
9.4.2 Pain Management Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Cancer Therapy
9.5.1 Cancer Therapy Market Trends Analysis (2020-2032)
9.5.2 Cancer Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Vaccine Delivery
9.6.1 Vaccine Delivery Market Trends Analysis (2020-2032)
9.6.2 Vaccine Delivery Market Size Estimates and Forecasts to 2032 (USD Billion)
9.7 Others
9.7.1 Others Market Trends Analysis (2020-2032)
9.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Microneedle Drug Delivery Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.2.4 North America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.2.5 North America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.2.6.2 USA Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.2.6.3 USA Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.2.7.2 Canada Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.2.7.3 Canada Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.2.8.3 Mexico Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.1.6.3 Poland Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.1.7.3 Romania Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.5 Western Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.6.3 Germany Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.7.2 France Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.7.3 France Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.8.3 UK Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.9.3 Italy Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.10.3 Spain Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.13.3 Austria Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Microneedle Drug Delivery Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.5 Asia Pacific Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.6.2 China Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.6.3 China Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.7.2 India Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.7.3 India Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.8.2 Japan Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.8.3 Japan Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.9.3 South Korea Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.10.3 Vietnam Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.11.3 Singapore Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.12.2 Australia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.12.3 Australia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Microneedle Drug Delivery Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.1.5 Middle East Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.1.6.3 UAE Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.2.4 Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.2.5 Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Microneedle Drug Delivery Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.6.4 Latin America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.6.5 Latin America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.6.6.3 Brazil Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.6.7.3 Argentina Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.6.8.3 Colombia Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Material (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Microneedle Drug Delivery Systems Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
11. Company Profiles
11.1 3M Healthcare
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Becton
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Dickinson and Company
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Zosano Pharma Corporation
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 NanoPass Technologies Ltd.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Corium, Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Valeritas Holdings, Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Raphas Co., Ltd.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Lohmann Therapie-Systeme AG (LTS)
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Micropoint Technologies
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Material
Silicon
Metal
Polymer
Others
By Type
Solid
Hollow
Dissolving
Coated
Others
By Application
Dermatology
Drug Delivery
Pain Management
Cancer Therapy
Vaccine Delivery
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Amniotic Membrane Market size was worth USD 3.65 billion in 2023 and is predicted to be worth USD 10.18 billion by 2032, growing at a CAGR of 12.10% Over the Forecast Period of 2024 and 2032.
The Medical Device Engineering Market size is expected to be valued at USD 10.98 Billion in 2023. It is estimated to reach USD 25.27 Billion by 2032, with a growing CAGR of 9.59% over the forecast period 2024-2032.
The Occupational Health Market size was valued at USD 4.98 billion in 2023 and is expected to reach USD 7.45 billion by 2032, growing at a CAGR of 4.62%.
The Blood Group Typing Market was estimated at USD 1.9 billion in 2023 and is poised to reach 4.05 billion in 2032 anticipated to expand at a compound annual growth rate of 8.8% for the forecast period of 2024-2032.
The Anxiety Disorders and Depression Treatment Market size was USD 11.89 Billion in 2023 and is expected to Reach USD 16.50 Billion by 2032 and grow at a CAGR of 3.5% over the forecast period of 2024-2032.
The Bone Morphogenetic Protein Market size was estimated at USD 0.53 billion in 2023 and is expected to reach USD 0.72 billion by 2032 with a growing CAGR of 3.50% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
